 |
[라포르시안] Ildong Pharmaceutical (CEO Yoon Woong-seop) announced on the 25th that it achieved good results in the overseas business field last year through marketing diversification.
Ildong Pharmaceutical’s overseas business performance in 2020 grew by about 59% compared to the same period last year thanks to the increase in exports of pharmaceuticals, raw materials, health functional foods, and cosmetics.
In the case of pharmaceuticals, related to Corona 19, there were special exports of emergency drugs such as antibiotics to Luxembourg and Singapore, and sales performance of synthetic pharmaceutical raw materials and vitamin raw materials, as well as existing finished drugs, expanded.
The export performance of consumer healthcare items such as health functional foods, functional cosmetics brand FIRST-LAB, including’MyNi series’ to China and Taiwan, has more than doubled compared to 2019.
In particular, the achievements gained by attempting to enter a famous online mall in China, live sales broadcasting through collaboration with Wang Hong (Tie, a famous Chinese influencer), and SNS marketing, etc.
According to Ildong Pharmaceutical, in a situation where it is difficult to secure a market due to the Corona 19 pandemic, it was effective to quickly respond with untouch marketing such as online and SNS instead of the conventional method.
An official from Ildong Pharmaceutical said, “The proportion of online and untact marketing is increasing in both domestic and overseas markets.” We plan to devote our capabilities to promoting collaboration as well as discovery.”
He added, “We plan to increase efficiency by unifying organizations related to overseas business, and to develop markets in neighboring regions such as Southeast Asia and Russia.”